Clinical Improvement in Pulmonary Arterial Hypertension (PAH) Patients Transitioning from Selexipag to Oral Treprostinil: Interim Results from the ADAPT Registry

被引：0
|
作者：
Lachant, D. [1 ]
Minkin, R. [2 ]
Swisher, J. [3 ]
Mogri, M. [4 ]
Zolty, R. [5 ]
Shelton, D. [6 ]
Seaman, S. [7 ]
Broderick, M. [7 ]
Sahay, S. [8 ]
机构：
[1] Univ Rochester, Med Ctr, Rochester, NY 14642 USA
[2] NewYork Presbyterian Brooklyn Methodist Hosp, Brooklyn, NY USA
[3] Ft Sanders Reg Med Ctr, Knoxville, TN USA
[4] Baylor Scott & White Pulm & Crit Care Specialists, Dallas, TX USA
[5] Univ Nebraska Med Ctr, Omaha, NE USA
[6] Univ N Carolina, Chapel Hill, NC 27515 USA
[7] United Therapeut Corp, Res Triangle Pk, NC USA
[8] Houston Methodist Lung Ctr, Houston, TX USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2022年 / 205卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3592
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Safety and efficacy of transitioning from selexipag to oral treprostinil in pulmonary arterial hypertension: Findings from the ADAPT registry
    Lachant, D.
    Minkin, R.
    Swisher, J.
    Mogri, M.
    Zolty, R.
    Hwang, S.
    Seaman, S.
    Broderick, M.
    Sahay, S.
    [J]. PULMONARY PHARMACOLOGY & THERAPEUTICS, 2023, 82
  • [2] Transitioning selexipag to oral treprostinil in patients with pulmonary artery hypertension
    Arevalo, Carlo
    White, R. James
    Lachant, Daniel
    [J]. RESPIRATORY MEDICINE CASE REPORTS, 2022, 37
  • [3] TRANSITION FROM SELEXIPAG TO ORAL TREPROSTINIL IN A PATIENT WITH PULMONARY ARTERIAL HYPERTENSION
    Patel, Amol
    Safdar, Zeenat
    [J]. CHEST, 2018, 154 (04) : 1023A - 1024A
  • [4] Transition from selexipag to oral treprostinil in a patient with pulmonary arterial hypertension
    Oriaku, Ifeoma
    Patel, Amol
    Safdar, Zeenat
    [J]. PULMONARY CIRCULATION, 2020, 10 (01)
  • [5] Transition From Oral Treprostinil to Selexipag in a Patient With Pulmonary Arterial Hypertension
    Verlinden, Nathan J.
    Walter, Claire
    Kanwar, Manreet
    Raina, Amresh
    [J]. ANNALS OF PHARMACOTHERAPY, 2019, 53 (07) : 764 - 765
  • [6] Safety And Tolerability Of Transitioning From Parenteral Treprostinil To Oral Treprostinil In Patients With Pulmonary Arterial Hypertension
    White, R. J.
    Chakinala, M. M.
    Mathier, M.
    Howell, M.
    Laliberte, K.
    Feldman, J.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [7] Safety And Tolerability Of Transitioning From Parenteral Treprostinil To Oral Treprostinil In Patients With Pulmonary Arterial Hypertension
    White, R. J.
    Chakinala, M.
    Rischard, F.
    Howell, M.
    Laliberte, K.
    Feldman, J.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [8] Transitioning from parenteral treprostinil to inhaled treprostinil in patients with pulmonary arterial hypertension
    Raina, Amresh
    Coons, James C.
    Kanwar, Manreet
    Murali, Srinivas
    Sokos, George
    Benza, Raymond L.
    [J]. PULMONARY CIRCULATION, 2013, 3 (01) : 116 - 120
  • [9] Transition From Inhaled Treprostinil to Selexipag in Pulmonary Arterial Hypertension
    El-Kersh, Karim
    Smith, J. Shaun
    [J]. AMERICAN JOURNAL OF THERAPEUTICS, 2017, 24 (05) : E620 - E621
  • [10] Transition from treprostinil to selexipag in patients with pulmonary arterial hypertension: Case series
    Fanous, Sherif M.
    Janmohamed, Munir
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2018, 75 (23) : 1877 - 1881
12345